Winslow Evans & Crocker’s Audentes Therapeutics, Inc BOLD Stock Holding History

Winslow Evans & Crocker’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-186	Closed	-$12K	–	1197
2019 Q4	$12K	Hold	186	–	–	﹤0.01%	805
2019 Q3	$6K	Buy	+186	New	+$6.35K	﹤0.01%	956

Winslow Evans & Crocker's BOLD Position: Q1 2020 in Review

Winslow Evans & Crocker sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 186 shares — an estimated $12K sold.

Winslow Evans & Crocker first reported a position in BOLD in Q3 2019 and held it in 2 quarters. The position peaked at $12K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Winslow Evans & Crocker reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Winslow Evans & Crocker sold 186 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $12K.
Winslow Evans & Crocker first reported a position in Audentes Therapeutics, Inc in Q3 2019 and held it in 2 quarters.
Winslow Evans & Crocker's Audentes Therapeutics, Inc position peaked at $12K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Winslow Evans & Crocker's 13F filing for Q1 2020, filed 20 Apr 2020.